Murawski A, Fabrizio T, Ossiboff R, Kackos C, Jeev. Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida. Commun Biol. 2024 Apr 18;7(1):476. Abstract submitted by kickingbird at 15 hours ago from Commun Biol. 2024 Apr 18;7(1):476 Since late 2021, highly pathogenic avian influenza (HPAI) viruses of A/goose/Guangdong/1/1996 (H5N1) lineage have caused widespread mortality in wild birds and poultry in the United States. Concomitant ... Umar S, Kim S, Gao D, Chen P. Evidence of Reverse Zoonotic Transmission of Human Seasonal Influenza A Virus (H1N1, H3N2) Among Cats. Influenza Other Respir Viruses. 2024 Apr;18(4):e13. Abstract submitted by kickingbird at 15 hours ago from Influenza Other Respir Viruses. 2024 Apr;18(4):e13 Human–animal interactions are closely intertwined. The connection between animal, human, and environmental health is becoming increasingly complicated with globalization, industrialization, and climate ... Liu Y, Chen Y, Yang Z, Lin Y, Fu S, Chen J, Xu L,. Evolution and Antigenic Differentiation of Avian Influenza A(H7N9) Virus, China. Emerg Infect Dis. 2024 Apr 19;30(6). Abstract submitted by kickingbird at 15 hours ago from Emerg Infect Dis. 2024 Apr 19;30(6) We characterized the evolution and molecular characteristics of avian influenza A(H7N9) viruses isolated in China during 2021-2023. We systematically analyzed the 10-year evolution of the hemagglutinin ... Hou Y, Deng G, Cui P, Zeng X, Li B, Wang D, He X,. Evolution of H7N9 highly pathogenic avian influenza virus in the context of vaccination. Emerg Microbes Infect. 2024 Apr 17:2343912. Abstract submitted by kickingbird at 2 days ago from Emerg Microbes Infect. 2024 Apr 17:2343912 Human infections with the H7N9 influenza virus have been eliminated in China through vaccination of poultry; however, the H7N9 virus has not yet been eradicated from poultry. Carefully analysis of H7N9 ... van der Pol S, Zeevat F, Postma MJ, Boersma C. Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations. Vaccine. 2024 Apr 17:S0264-410X(24)00465-1. Abstract submitted by kickingbird at 2 days ago from Vaccine. 2024 Apr 17:S0264-410X(24)00465-1 Objectives: We assess the cost-effectiveness of switching from standard-dose quadrivalent influenza vaccination (SD-QIV) to high-dose vaccination (HD-QIV) for Dutch adults aged 60 years and older.Methods: ... | |